In this sense, inhibition of Hsp90 has shown an antitumor effect in animal models of CRC and in CRC cell lines as it caused the depletion of B-RAF and K-RAS, which are major oncogenic drivers in CRC associated with poor disease prognosis [88]. This evidence concerns the gene KRAS and colorectal carcinoma.